Effects of Dapagliflozi N a Nd N-3 Carboxylic Acids O N No N-Alcoholic Fatty Liver Disease I N People with Type 2 Diabetes: a Double-Bli Nd Ra Ndomised Placebo-Co Ntrolled Study

Jan W. Eriksson,Per Lundkvist,Per-Anders Jansson,Lars Johansson,Mats Kvarnström,Linda Moris,Tasso Miliotis,Gun-Britt Forsberg,Ulf Risérus,Lars Lind,Jan Oscarsson

Diabetologia（2018）

引用 270|浏览52

暂无评分

摘要

The EFFECT-II study aimed to investigate the effects of dapagliflozin and omega-3 (n-3) carboxylic acids (OM-3CA), individually or combined, on liver fat content in individuals with type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).

查看译文

关键词

Dapagliflozin,Docosahexaenoic acid,Eicosapentaenoic acid,Liver steatosis,Non-alcoholic fatty liver disease,Omega-3 fatty acids,Proton density fat fraction,Type 2 diabetes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要